$NPSP Recent News 15 small-cap stocks Goldman Sachs

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$NPSP Recent News

15 small-cap stocks Goldman Sachs says are worth a look 11:51 a.m. July 22, 2014 - blogs.marketwatch.com
Nasdaq rattles cage on major resistance 10:31 a.m. June 5, 2014 - Michael Ashbaugh
3 best hedge fund managers of 2013 2:50 p.m. Jan. 22, 2014 - Insider Monkey
This is not a bursting bubble 2:06 p.m. Jan. 14, 2014 - The Trading Deck
Charting the S&P 500’s next technical target 12:43 p.m. Dec. 19, 2013 - Michael Ashbaugh
Hedge funder Michael Castor's top pick for 2016 11:58 a.m. Sept. 20, 2013 - The Trading Deck
Charting a market divergence 11:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Manager David Simon's top three stock picks 11:03 a.m. July 26, 2013 - The Trading Deck
Charting a Fed-induced market whipsaw 11:38 a.m. May 23, 2013 - Michael Ashbaugh
3 stock picks from the next David Einhorn 8:01 a.m. March 29, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 7:43 a.m. March 20, 2013 - Shawn Langlois
Major U.S. benchmarks reach firmer ground 12:11 p.m. Nov. 29, 2012 - Michael Ashbaugh
Charting the bull/bear debate 2:06 p.m. Nov. 20, 2012 - Michael Ashbaugh
Charting the bull/bear debate 1:42 p.m. Nov. 20, 2012 - Michael Ashbaugh
Friday’s biggest gaining and declining stocks 4:33 p.m. June 22, 2012 - MarketWatch
NPS jumps on EU regulatory update 1:58 p.m. June 22, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:17 p.m. Oct. 31, 2011 - Kate Gibson
NPS Pharmaceuticals plunges on drug study 12:48 p.m. Oct. 31, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:35 p.m. Jan. 31, 2011 - Kate Gibson
Depomed, NPS lead drug stocks higher 5:19 p.m. Jan. 31, 2011 - Val Brickates Kennedy


Perilous Reversal Watch: NPS Pharmaceuticals (NPSP) 9:46 a.m. Today - TheStreet.com
Does New Data Make or Break NPS Pharmaceuticals? 2:18 p.m. Sept. 10, 2014 - 247WallSt.com
Why NPS Pharmaceuticals (NPSP) Stock is Surging Today 1:11 p.m. Sept. 10, 2014 - TheStreet.com
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog 11:17 a.m. Sept. 10, 2014 - Zacks.com
Benzinga's Volume Movers 9:20 a.m. Sept. 10, 2014 - benzinga.com
Natpara Ad Comm review on tap for Friday 9:00 a.m. Sept. 10, 2014 - Seeking Alpha
Heavy Volume And Pre-Market Movement For NPS Pharmaceuticals (NPSP) 8:58 a.m. Sept. 10, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – NPSP LGND AVNR AUXL 8:45 a.m. Sept. 10, 2014 - InvestorPlace.com
FDA Posts Briefing Materials For Advisory Committee Meeting Reviewing Natpara For Hypoparathyroidism 7:07 a.m. Sept. 10, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PTCT NPSP UTHR OPK 2:00 p.m. Sept. 8, 2014 - InvestorPlace.com
NPS Pharmaceuticals, Inc. (NPSP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Sept. 5, 2014 - Zacks.com
Bearish sell-off in NPS Pharma ahead of Ad Comm meeting 3:41 p.m. Sept. 4, 2014 - Seeking Alpha
NPS Pharma: Important Catalyst Coming Next Week 4:52 p.m. Sept. 3, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – NPSP PRXL GB THOR 1:00 p.m. Sept. 3, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – AVNR NPSP IRWD DGX 2:00 p.m. Aug. 29, 2014 - InvestorPlace.com
NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog 12:40 p.m. Aug. 7, 2014 - Zacks.com
NPS Pharmaceuticals' (NPSP) CEO Francois Nader on Q2 2014 Results - Earnings Call Transcript 11:39 p.m. Aug. 6, 2014 - Seeking Alpha
NPS Pharmaceuticals (NPSP) Q2 2014 Results - Earnings Call Webcast 4:55 p.m. Aug. 6, 2014 - Seeking Alpha
Goldman's picks in small caps 12:45 p.m. Aug. 5, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts-Part 3 2:36 p.m. Aug. 4, 2014 - Seeking Alpha


FDA Posts Briefing Materials for Advisory Committee Meeting Reviewing Natpara® for Hypoparathyroidism 8:05 a.m. Sept. 10, 2014 - BusinessWire - BZX
Acucela Appoints Biotechnology Industry Veteran and Former Pharmaceutical Executive, Brian O’Callaghan, as Its New President and Chief Operating Officer and Interim CFO; Ryo Kubota, MD, PhD, to Remain in His Role as Chairman and CEO 8:15 p.m. Sept. 8, 2014 - BusinessWire - BZX
Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 9:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
NPS Pharma Reports Second-Quarter 2014 Financial Results 12:07 a.m. Aug. 7, 2014 - BusinessWire - BZX
Critical Alerts For NPS Pharmaceuticals, Qualys, General Motors, Lockheed Martin, and Navistar International Released By InvestorsObserver 9:31 a.m. Aug. 6, 2014 - PR Newswire - PRF
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
NPS Pharma to Present at Upcoming Conferences 8:11 a.m. Aug. 5, 2014 - BusinessWire - BZX
NPS Pharma Initiates Phase 2a Study of NPSP795 in Adult Patients with Autosomal Dominant Hypocalcemia (ADH) 8:10 a.m. Aug. 4, 2014 - BusinessWire - BZX
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 9:00 a.m. July 30, 2014 - PR Newswire - PRF
NPS Pharma to Report Second Quarter 2014 Financial Results 8:10 a.m. July 29, 2014 - BusinessWire - BZX
PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism 8:47 a.m. July 24, 2014 - BusinessWire - BZX
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
FDA Approves Updated Labeling for Gattex® (Teduglutide [rDNA origin]) for Injection to Include Long-Term Data 8:31 a.m. June 30, 2014 - BusinessWire - BZX
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 7:50 a.m. June 27, 2014 - PR Newswire - PRF
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
NPS Pharma Reports Change in Tentative Date of FDA Advisory Committee Review of Natpara® BLA to September 12 - PDUFA Date of October 24 Remains Unchanged 8:31 a.m. June 10, 2014 - BusinessWire - BZX
Critical Alerts For SunPower, Broadcom, NPS Pharmaceuticals, General Motors, and YY Technology Released By InvestorsObserver 9:31 a.m. June 9, 2014 - PR Newswire - PRF
NPS Pharma to Present at Goldman Sachs Global Healthcare Conference 4:10 p.m. June 3, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of NPS Pharmaceuticals, Inc. - NPSP 12:34 p.m. June 2, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 0

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 0

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 1

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 3

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 2

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 3

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 8

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Fenix24 and Partners Recognized for Outstanding Cybersecurity

Updated Category News Views 306

Fenix24 and Partners Shine in Global Cybersecurity Awards Fenix24, a leading cyber disaster recovery firm, has affirmed its position as a market leader following recent recognitions in the cybersecurity sector. This award from the Cyber Defense Magazine showcases Fenix24’s commitment to setting new standards in breach recovery and incident response, fostering...

Continue Reading
Savara Inc. Shareholders: Your Chance to Join the Legal Battle

Updated Category News Views 207

Understanding the Opportunity for Action Investors holding shares of Savara Inc. (NASDAQ: SVRA) may find an important opportunity to engage in a class action lawsuit. The law firm spearheading this effort, known for its focus on shareholder rights, is reaching out to those affected by possible misstatements made by the company. What Led to the Class Action Lawsuit? The...

Continue Reading
Brennan Investment Group Expands Portfolio with Major Acquisition

Updated Category News Views 415

Brennan Investment Group's Strategic Move in the Industrial Market Brennan Investment Group has made a significant stride in the industrial real estate sector with its recent acquisition of an expansive industrial campus previously owned by Innovex. This strategic move marks one of the largest transactions in the region this year, emphasizing the group's commitment to...

Continue Reading
ViaSat Faces Competition From Starlink in Connectivity Market

Updated Category News Views 240

ViaSat's Position in the Market Amid Starlink's Rise Deutsche Bank recently reaffirmed its Hold rating on ViaSat (NASDAQ: VSAT), setting a target price of $22. This update comes after noticeable shifts in the inflight connectivity market, particularly with Starlink emerging as a formidable competitor by securing contracts for about 2,500 aircraft, which includes both...

Continue Reading
Stellantis NV: Short Interest Shift Sparks Investor Sentiment Questions

Updated Category News Views 231

Stellantis NV's (NYSE:STLA) short interest saw a notable drop of 13.81% since its last report, now standing at 44.96 million shares sold short, or about 1.56% of all tradable shares. Sounds like good news, right? But hang on—this isn't just a free pass to pop the champagne. When we talk short interest, we're peeling back layers on market sentiment that can turn on a...

Continue Reading